Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
fingolimod
i
Other names:
FTY 720, TDI-132, FTY-720, FTY720
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(4)
News
Trials
Company:
Generic mfg.
Drug class:
S1P receptor modulator
Related drugs:
‹
sonepcizumab (0)
sonepcizumab (0)
›
Associations
(4)
News
Trials
VERI cancer hierarchy
Reset Filters
FLT3-ITD mutation
Acute Myelogenous Leukemia
FLT3-ITD mutation
Acute Myelogenous Leukemia
gilteritinib + quizartinib + fingolimod
Sensitive: C3 – Early Trials
gilteritinib + quizartinib + fingolimod
Sensitive
:
C3
gilteritinib + quizartinib + fingolimod
Sensitive: C3 – Early Trials
gilteritinib + quizartinib + fingolimod
Sensitive
:
C3
FLT3-ITD expression
Acute Myelogenous Leukemia
FLT3-ITD expression
Acute Myelogenous Leukemia
FLT3 inhibitor + fingolimod
Sensitive: D – Preclinical
FLT3 inhibitor + fingolimod
Sensitive
:
D
FLT3 inhibitor + fingolimod
Sensitive: D – Preclinical
FLT3 inhibitor + fingolimod
Sensitive
:
D
FLT3-ITD mutation
Acute Myelogenous Leukemia
FLT3-ITD mutation
Acute Myelogenous Leukemia
venetoclax + fingolimod
Sensitive: D – Preclinical
venetoclax + fingolimod
Sensitive
:
D
venetoclax + fingolimod
Sensitive: D – Preclinical
venetoclax + fingolimod
Sensitive
:
D
FLT3-ITD mutation
Acute Myelogenous Leukemia
FLT3-ITD mutation
Acute Myelogenous Leukemia
fingolimod
Sensitive: D – Preclinical
fingolimod
Sensitive
:
D
fingolimod
Sensitive: D – Preclinical
fingolimod
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login